Guadecitabine sodium (SGI-110 sodium; S-110 sodium), a dinucleotide consisting of 5-Aza-CdR followed by a deoxyguanosine, is a novel and potent DNA methyltransferases (DNMT) inhibitor with the potential to be used for treating acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).

纯度：≥98%

CAS：929904-85-8